Andreas Halvorsen's position in BioNTech SE is currently worth $89.2 Million. That's 0.29% of their equity portfolio (61st largest holding). The investor's estimated purchase price is $106 Million, resulting in a loss of 16%.
Avg closing price
Price range
Increased shares by 1932.3% (+895 Thousand shares)
Q4 2024